Publications by authors named "Janet M Beanan"

Claim this Profile
A
Antibody Dependent Enhancement of Infection in a Mouse Pneumonia Model.
Shun Xin Wang-Lin, Ruth Olson, Janet M Beanan, Ulrike MacDonald, Thomas A Russo

J Pharmacol Exp Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
Shun Xin Wang-Lin, Ruth Olson, Janet M Beanan, Ulrike MacDonald, Joseph P Balthasar

Infect Immun· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.
Thomas A Russo, Akshay Manohar, Janet M Beanan, Ruth Olson, Ulrike MacDonald

mSphere· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.
Kristin A Sutton, Jennifer Breen, Ulrike MacDonald, Janet M Beanan, Ruth Olson

Acta Crystallogr D Biol Crystallogr· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.
Thomas A Russo, Janet M Beanan, Ruth Olson, Ulrike MacDonald, Andrew D Cox

Infect Immun· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.
Timothy C Umland, L Wayne Schultz, Ulrike MacDonald, Janet M Beanan, Ruth Olson

mBio· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model.
Qingli Kong, Janet M Beanan, Ruth Olson, Ulrike Macdonald, Alyssa S Shon

Virulence· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence.
Thomas A Russo, Alyssa S Shon, Janet M Beanan, Ruth Olson, Ulrike MacDonald

PLoS One· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii.
Thomas A Russo, Malcolm G P Page, Janet M Beanan, Ruth Olson, Andrea M Hujer

J Antimicrob Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.
Thomas A Russo, Nicole R Luke, Janet M Beanan, Ruth Olson, Shauna L Sauberan

Infect Immun· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis.
Nicole R Luke, Shauna L Sauberan, Thomas A Russo, Janet M Beanan, Ruth Olson

Infect Immun· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo.
Thomas A Russo, Ulrike MacDonald, Janet M Beanan, Ruth Olson, Ian J MacDonald

J Infect Dis· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.
Thomas A Russo, Janet M Beanan, Ruth Olson, Ulrike MacDonald, John J Cope

Vaccine· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.
Thomas A Russo, Janet M Beanan, Ruth Olson, Ulrike MacDonald, Nicole R Luke

Infect Immun· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capsule and O-antigen from an extraintestinal isolate of Escherichia coli modulate cytokine levels in rat macrophages in vitro and in a rat model of pneumonia.
Thomas A Russo, Bruce A Davidson, Janet M Beanan, Ruth Olson, Bruce A Holm

Exp Lung Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.
Thomas A Russo, Janet M Beanan, Ruth Olson, Stacy A Genagon, Ulrike MacDonald

Vaccine· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model.
Thomas A Russo, Zhengdong Wang, Bruce A Davidson, Stacy A Genagon, Janet M Beanan

Am J Physiol Lung Cell Mol Physiol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.
Thomas A Russo, Bruce A Davidson, Stacy A Genagon, Natalie M Warholic, Ulrike Macdonald, Janet M Beanan

Am J Physiol Lung Cell Mol Physiol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.
Thomas A Russo, Catherine D McFadden, Ulrike B Carlino-MacDonald, Janet M Beanan, Ruth Olson

Infect Immun· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.
Thomas A Russo, Catherine D McFadden, Ulrike B Carlino-MacDonald, Janet M Beanan, Travis J Barnard

Infect Immun· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis